Heparin compromises streptokinase-induced arterial patency in rabbits

Thrombosis Research

Volumn 115, Issue 5, 2005, Pages 427-434

  Vlasin, M ^a,b   Rak, J ^a   Weitz, J I ^a   Peng, L ^a   Gumulec, J ^c   Johnston, M ^a   Klement, P ^a,b,c,d  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c Oncologic Center JG Mendel   (Czech Republic)

^d HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

Critical stenosis; Fibrinogen consumption; Streptokinase induced arterial patency

Indexed keywords

ENOXAPARIN; FIBRINOGEN; FIBRINOLYTIC AGENT; HEPARIN; HEPARINOID; HIRUDIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; AORTA THROMBOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RABBIT; RECANALIZATION; THROMBIN TIME; VASCULAR PATENCY;

EID: 14144251562     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.09.013     Document Type: Conference Paper

References (28)

1. M.A. DeWood, J. Spores, R. Notske, L.T. Mouser, R. Burroughs, and M.S. Golden Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction N. Engl. J. Med. 303 1980 897 902
2. Y. Dundar, R. Hill, R. Dickson, and T. Walley Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review Q. J. Med. 96 2003 103 113
3. C.-K. Wong, and D. White Medical treatment for acute coronary syndromes Curr. Opin. Cardiol. 15 2000 441 462
4. E.J. Topol Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence Circulation 97 1998 211 218
5. GUSTO Angiographic Investigators The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after myocardial infarction N. Engl. J. Med. 329 1993 1615 1622
6. G.A. Ewald, and P.R. Eisenberg Increased procoagulant activity in response to fibrinolytic agents due to plasmin-mediated activation of the contact system Thromb. Haemost. 69 1993 1004 [abstract]
7. H.J. Rapold Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation Lancet 2 1989 77 181
8. D.J. Fitzgerald, F. Catella, L. Roy, and G.A. Fitzgerald Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction N. Engl. J. Med. 77 1988 142 150
9. J. Owen, K.D. Friedman, B.A. Grossman, C. Wilkins, A.D. Berke, and E.R. Powers Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity Blood 72 1988 616 620
10. P.A. Merlini, K. Bauer, L. Oltrona, D. Ardissino, A. Spinola, and M. Cattaneo Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction J. Am. Coll. Cardiol. 25 1995 203 209
11. Alexander JH, Grander CB, Califf RM, White HD, Hochman J, Topol EJ, et-al. For the ASSENT-2 investigators, Duke Clinic Research Institute, Durham NC, USA. Higher aPTTs associated with worse outcomes after thrombolytic therapy with reduced-dose heparin: Results from ASSENT-2. JACC 2000; 372A [Abstract # 1106-105].
12. D.R. Thiemann, J. Coresh, S.P. Schulman, G. Gerstenblith, W.S. Oetgen, and N.R. Powe Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years Circulation 101 2000 2239 2246
13. M. Galvani, D.R. Abendschein, D. Ferrini, F. Ottani, F. Rusticali, and P.R. Eisenberg Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase J. Am. Coll. Cardiol. 24 1994 1445 1452
14. D.W. Nilsen, L. Goransson, A.I. Larsen, O. Hetland, and P. Kierulf Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction Thromb. Haemost. 77 1997 57 61
15. D.L. Becker, J.C. Fredenburgh, A.R. Stafford, and J.I. Weitz Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II J. Biol. Chem. 274 1999 6226 6233
16. R. Kumar, S. Beguin, and C. Hemker The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity Thromb. Haemost. 74 1995 962 968
17. P.J. Hogg, and C.M. Jackson Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex J. Biol. Chem. 265 1990 241 247
18. P. Klement, A. Borm, J. Hirsh, J. Maraganore, G. Wilson, and J.I. Weitz The effect of thrombin inhibitors on tissue plasminogen activator-induced thrombolysis in rat model Thromb. Haemost. 68 1992 64 68
19. P. Klement, S. Carlsson, J. Rak, P. Liao, M. Vlasin, and A. Stafford The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model J. Thromb. Haemost. 1 2003 587 594
20. P. Klement, P. Liao, and L. Bajzar A novel approach to arterial thrombolysis Blood 94 1999 2735 2743
21. R.R. Proctor, and S.I. Rapaport The partial thromboplastin time with kaolin Am. J. Clin. Pathol. 36 1961 212 219
22. W.H. Seeger, and H.P. Smith Factors which influence the activity of purified thrombin Am. J. Physiol. 137 1942 348 354
23. A. Clauss Gerinnugphysiologishe schnell methode zur bestimmung des fibrinogeus Acta Haematol. 17 1957 237 341
24. C. Speidel, P.R. Eisenberg, W. Ruf, T. Edgington, and D.R. Abendschein Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits Circulation 92 1995 3323 3330
25. J. Van Ryn-McKenna, F.A. Ofosu, and M.R. Buchanan The effect of heparin and dermatan sulphate on t-PA-induced thrombolysis and blood loss in rabbits Fibrinolysis 7 1993 75 81
26. M. Heras, J.H. Chesebro, M.W.I. Webster, J.S. Mruk, D.E. Grill, and W.J. Penny Hirudin, heparin and placebo during deep arterial injury in the pig. The in-vivo role of thrombin in platelet-mediated thrombosis Circulation 82 1990 1476 1484
27. E.C. Smoot, A. Marx, D. Weiman, and S.R. Deitcher Recognition, diagnosis and management of heparin-induced thrombocytopenia and thrombosis Plast. Reconstr. Surg. 103 1999 559 565
28. A.K.C. Chan, J. Rak, L. Berry, P. Liao, M. Vlasin, and J. Weitz Antithrombin-heparin covalent complex a possible alternative to heparin for arterial thrombosis prevention Circulation 106 2002 261 265